CMLHope.Com
A Worldwide Support Network For Chronic Myelogenous Leukemia
Posted by rob on August 10, 2007 under Uncategorized | Be the First to Comment
Quantitative monitoring by polymerase colony assay of known mutations resistant to ABL kinase inhibitors.
Establishment of baseline toxicity expectations with standard frontline chemotherapy in acute myelogenous leukemia.
You must be logged in to post a comment.
Add A Comment
You must be logged in to post a comment.